Ludwig-Maximilians University
Munich, 812377, Germany
NCT Number: NCT03479840
The SYNTAX-score has been proposed as a tool for risk stratification and guiding revascularization therapy in patients with complex coronary artery disease.
There are limited data on the prognostic value of the SYNTAX-score among elderly patients.
Aim of this study was to investigate whether age modifies the impact of the SYNTAX-score on all-cause mortality at 2 years after percutaneous coronary intervention (PCI).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Munich, 812377, Germany
SYNTAX score has been used as a tool to quantify severity of coronary artery disease. Interventional or operative treatment of patients is associated with improvement in SYTAX score after PCI so called residual SYNTAX score. The higher the SYNTAX score value the higher is the mortality. Whereas this is true for both young and old patients is debatable. Therefore we aim to investigate in this registry age-dependent impact of baseline and residual SYNTAX score on 1- and 2-year mortality after PCI
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
treatment of coronary arteries and evaluation of SYNTAX score pre and post (to quantify severity of disease)
Other names: percutaneous coronary intervention
Time frame: 2 years
Overall mortality
LMU Klinikum
Other
Age-Dependent Impact of the SYNTAX-score on Mortality After Percutaneous Coronary Intervention in an All-Comer Population
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03023020
Arterial Occlusive Diseases, Arteriosclerosis
Buenos Aires, Argentina
View Trial DetailsNCT04310046
Aortic Stenosis, Aortic Valve Disease
Klagenfurt, Austria
View Trial DetailsNCT07269366
Arterial Occlusive Diseases, Arteriosclerosis
Groningen, Netherlands
View Trial DetailsNCT06499207
Arterial Occlusive Diseases, Arteriosclerosis
View Trial Details